Nuclear Medicine/Radiopharmaceuticals Market – Global Industry Analysis and Forecast (2023-2029)

Nuclear Medicine/Radiopharmaceuticals Market Size in 2022 was worth US $ 5.55 Bn at a CAGR 9 % and it is expected to reach US $ 10.14 Bn in 2029. Nuclear Medicine/Radiopharmaceuticals is used for diagnosis and treatment of various diseases that conventional medicines fail to achieve. Nuclear Medicine/Radiopharmaceuticals diagnose certain medical problems or treat certain diseases condition with various agents. Nuclear Medicine,Radiopharmaceuticals MarketTo know about the Research Methodology :- Request Free Sample Report Global Nuclear Medicine/Radiopharmaceuticals Market is segmented by type, procedural volume, application, and geography. Type segment is sub segmented as diagnostic nuclear medicine and therapeutic nuclear medicine/ radiopharmaceuticals. Application segment is divided into Diagnostic Applications, Therapeutic Applications, and Other Therapeutic Applications. SPECT application segment is expected to register highest market growth during the forecast period, owing to SPECT presence of well-established imaging market and the extensive usage of SPECT radioisotopes for the diagnosis of cancer, cardiovascular diseases, thyroid, and neurological disorders. The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Increasing incidence and prevalence of cancer and cardiac ailments are trending the overall Global Nuclear Medicine/Radiopharmaceuticals Market. However, a high cost of nuclear medicine equipment will restrain the market growth. North America is expected to dominate the Nuclear Medicine/Radiopharmaceuticals Market in forecast period followed by Europe and APAC. Presence of a well establish healthcare industry for the adoption of modern treatments and diagnostic procedures and raising awareness regarding the advantages that radiopharmaceuticals have to offer will fuel the Nuclear Medicine/Radiopharmaceuticals Market in North America region. Nuclear Medicine/Radiopharmaceuticals Market Key Highlights: 1. Assessment of market definition along with the identification of key players and an analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints, and challenges for this market during the forecast period 2. Complete quantitative analysis of the industry from 2017 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities 3. In-depth analysis of the industry on the basis of market segments, market dynamics, market size, competition & companies involved value chain 4. Global Nuclear Medicine/Radiopharmaceuticals Market analysis and comprehensive segmentation with respect to the type, procedural volume, application, and geography to assist in strategic business planning 5. Global Nuclear Medicine/Radiopharmaceuticals Market analysis and forecast for five major geographies North America, Europe, Asia Pacific, Middle East & Africa, Latin America and their key regions

Nuclear Medicine/Radiopharmaceuticals Market Research Methodology

The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the global market value for Global Nuclear Medicine/Radiopharmaceuticals Market. Research report categorizes the Global Nuclear Medicine/Radiopharmaceuticals Market based on type, procedural volume, application, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Nuclear Medicine/Radiopharmaceuticals Market with key developments in companies and market trends. The objective of the report is to present comprehensive Global Nuclear Medicine/Radiopharmaceuticals Market  including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Nuclear Medicine/Radiopharmaceuticals Market  North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Global Nuclear Medicine/Radiopharmaceuticals Market  North America for Asia Pacific   size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Nuclear Medicine/Radiopharmaceuticals Market  North America for Asia Pacific make the report investor’s guide. Key Target Audience: 1. Research and Consulting Firms as well as Venture capitalists, private equity firms, and startup companies 2. Radiopharmaceutical/Radioisotope Manufacturers and Distributors 3. Healthcare Institutions (Hospitals, Medical Schools, and Outpatient Clinics) 4. Contract Manufacturing Organizations (CMOs) 5. Contract research organizations (CROs) 6. Government Bodies

 Nuclear Medicine/Radiopharmaceuticals Market Scope: Inquire before buying

Global Nuclear Medicine/Radiopharmaceuticals Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 5.55 Bn.
Forecast Period 2023 to 2029 CAGR: 9% Market Size in 2029: US $ 10.14 Bn.
Segments Covered: by Procedures Cardiovascular Oncology Central Nervous System Skeletal Endocrine Gastrointestinal Pulmonary
by Type Therapeutic Alpha Emitters Beta Emitters Brachytherapy Isotopes Diagnostic PET Radiopharmaceuticals SPECT Radiopharmaceuticals
by Application Cardiology Oncology Thyroid Neurology Others
by End-User Research Institutes Hospitals Diagnostic Centers Others

Nuclear Medicine/Radiopharmaceuticals Market, By Geography

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Key Players in the Global Nuclear Medicine/Radiopharmaceuticals Market Are:

1. Advanced Accelerator Applications S.A.  2. Iba Molecular 3. Nordion, Inc. (A Subsidiary of Sterigenics International LLC.) 4. Eczacibasi-Monrol Nuclear Products 5. Siemens Healthcare 6. Sigma Aldrich Corporation 7. Bracco Imaging S.P.A 8. Bayer AG 9. Jubilant Pharma 10.Nordien, Inc. 11.Lantheus Medical Imaging, Inc. 12.GE Healthcare (A Fully-Owned Subsidiary of General Electric Company) 13.Mallinckrodt PLC 14.Cardinal Health, Inc. 15.Medtronic Plc. 16.Norgine B. V. 17.Curium 18.Eckert & Ziegler 19.NTP Radioisotopes Frequently Asked Questions: 1. What is the growth rate of Global Nuclear Medicine/Radiopharmaceuticals Market? Ans: The Global Nuclear Medicine/Radiopharmaceuticals Market is growing at a CAGR of 9 % during forecasting period 2023-2029. 2. What segments are covered in Global Nuclear Medicine/Radiopharmaceuticals market? Ans: Global Nuclear Medicine/Radiopharmaceuticals Market is segmented into by Type, process, application, End-user and Region. 3. Who are the key players in Global Nuclear Medicine/Radiopharmaceuticals market? Ans: Advanced Accelerator Applications S.A., Iba Molecular , Nordion, Inc. (A Subsidiary of Sterigenics International LLC.) , Eczacibasi-Monrol Nuclear Products , Siemens Healthcare , Sigma Aldrich Corporation , Bracco Imaging S.P.A 4. What is the study period of this market? Ans: The Global Nuclear Medicine/Radiopharmaceuticals Market is studied from 2022 to 2029.
1. Nuclear Medicine/Radiopharmaceuticals Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Nuclear Medicine/Radiopharmaceuticals Market: Dynamics 2.1. Nuclear Medicine/Radiopharmaceuticals Market Trends by Region 2.1.1. North America Nuclear Medicine/Radiopharmaceuticals Market Trends 2.1.2. Europe Nuclear Medicine/Radiopharmaceuticals Market Trends 2.1.3. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Trends 2.1.4. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Trends 2.1.5. South America Nuclear Medicine/Radiopharmaceuticals Market Trends 2.2. Nuclear Medicine/Radiopharmaceuticals Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Nuclear Medicine/Radiopharmaceuticals Market Drivers 2.2.1.2. North America Nuclear Medicine/Radiopharmaceuticals Market Restraints 2.2.1.3. North America Nuclear Medicine/Radiopharmaceuticals Market Opportunities 2.2.1.4. North America Nuclear Medicine/Radiopharmaceuticals Market Challenges 2.2.2. Europe 2.2.2.1. Europe Nuclear Medicine/Radiopharmaceuticals Market Drivers 2.2.2.2. Europe Nuclear Medicine/Radiopharmaceuticals Market Restraints 2.2.2.3. Europe Nuclear Medicine/Radiopharmaceuticals Market Opportunities 2.2.2.4. Europe Nuclear Medicine/Radiopharmaceuticals Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Drivers 2.2.3.2. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Restraints 2.2.3.3. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Opportunities 2.2.3.4. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Drivers 2.2.4.2. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Restraints 2.2.4.3. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Opportunities 2.2.4.4. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Challenges 2.2.5. South America 2.2.5.1. South America Nuclear Medicine/Radiopharmaceuticals Market Drivers 2.2.5.2. South America Nuclear Medicine/Radiopharmaceuticals Market Restraints 2.2.5.3. South America Nuclear Medicine/Radiopharmaceuticals Market Opportunities 2.2.5.4. South America Nuclear Medicine/Radiopharmaceuticals Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Nuclear Medicine/Radiopharmaceuticals Industry 2.8. Analysis of Government Schemes and Initiatives For Nuclear Medicine/Radiopharmaceuticals Industry 2.9. Nuclear Medicine/Radiopharmaceuticals Market Trade Analysis 2.10. The Global Pandemic Impact on Nuclear Medicine/Radiopharmaceuticals Market 3. Nuclear Medicine/Radiopharmaceuticals Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 3.1.1. Cardiovascular 3.1.2. Oncology 3.1.3. Central Nervous System 3.1.4. Skeletal 3.1.5. Endocrine 3.1.6. Gastrointestinal 3.1.7. Pulmonary 3.2. Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 3.2.1. Therapeutic 3.2.2. Alpha Emitters 3.2.3. Beta Emitters 3.2.4. Brachytherapy Isotopes 3.2.5. Diagnostic 3.2.6. PET Radiopharmaceuticals 3.2.7. SPECT Radiopharmaceuticals 3.3. Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 3.3.1. Cardiology 3.3.2. Oncology 3.3.3. Thyroid 3.3.4. Neurology 3.3.5. Others 3.4. Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 3.4.1. Research Institutes 3.4.2. Hospitals 3.4.3. Diagnostic Centers 3.4.4. Others 3.5. Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Region (2022-2029) 3.5.1. North America 3.5.2. Europe 3.5.3. Asia Pacific 3.5.4. Middle East and Africa 3.5.5. South America 4. North America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 4.1.1. Cardiovascular 4.1.2. Oncology 4.1.3. Central Nervous System 4.1.4. Skeletal 4.1.5. Endocrine 4.1.6. Gastrointestinal 4.1.7. Pulmonary 4.2. North America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 4.2.1. Therapeutic 4.2.2. Alpha Emitters 4.2.3. Beta Emitters 4.2.4. Brachytherapy Isotopes 4.2.5. Diagnostic 4.2.6. PET Radiopharmaceuticals 4.2.7. SPECT Radiopharmaceuticals 4.3. North America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 4.3.1. Cardiology 4.3.2. Oncology 4.3.3. Thyroid 4.3.4. Neurology 4.3.5. Others 4.4. North America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 4.4.1. Research Institutes 4.4.2. Hospitals 4.4.3. Diagnostic Centers 4.4.4. Others 4.5. North America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Country (2022-2029) 4.5.1. United States 4.5.1.1. United States Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 4.5.1.1.1. Cardiovascular 4.5.1.1.2. Oncology 4.5.1.1.3. Central Nervous System 4.5.1.1.4. Skeletal 4.5.1.1.5. Endocrine 4.5.1.1.6. Gastrointestinal 4.5.1.1.7. Pulmonary 4.5.1.2. United States Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 4.5.1.2.1. Therapeutic 4.5.1.2.2. Alpha Emitters 4.5.1.2.3. Beta Emitters 4.5.1.2.4. Brachytherapy Isotopes 4.5.1.2.5. Diagnostic 4.5.1.2.6. PET Radiopharmaceuticals 4.5.1.2.7. SPECT Radiopharmaceuticals 4.5.1.3. United States Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 4.5.1.3.1. Cardiology 4.5.1.3.2. Oncology 4.5.1.3.3. Thyroid 4.5.1.3.4. Neurology 4.5.1.3.5. Others 4.5.1.4. United States Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 4.5.1.4.1. Research Institutes 4.5.1.4.2. Hospitals 4.5.1.4.3. Diagnostic Centers 4.5.1.4.4. Others 4.5.2. Canada 4.5.2.1. Canada Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 4.5.2.1.1. Cardiovascular 4.5.2.1.2. Oncology 4.5.2.1.3. Central Nervous System 4.5.2.1.4. Skeletal 4.5.2.1.5. Endocrine 4.5.2.1.6. Gastrointestinal 4.5.2.1.7. Pulmonary 4.5.2.2. Canada Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 4.5.2.2.1. Therapeutic 4.5.2.2.2. Alpha Emitters 4.5.2.2.3. Beta Emitters 4.5.2.2.4. Brachytherapy Isotopes 4.5.2.2.5. Diagnostic 4.5.2.2.6. PET Radiopharmaceuticals 4.5.2.2.7. SPECT Radiopharmaceuticals 4.5.2.3. Canada Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 4.5.2.3.1. Cardiology 4.5.2.3.2. Oncology 4.5.2.3.3. Thyroid 4.5.2.3.4. Neurology 4.5.2.3.5. Others 4.5.2.4. Canada Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 4.5.2.4.1. Research Institutes 4.5.2.4.2. Hospitals 4.5.2.4.3. Diagnostic Centers 4.5.2.4.4. Others 4.5.3. Mexico 4.5.3.1. Mexico Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 4.5.3.1.1. Cardiovascular 4.5.3.1.2. Oncology 4.5.3.1.3. Central Nervous System 4.5.3.1.4. Skeletal 4.5.3.1.5. Endocrine 4.5.3.1.6. Gastrointestinal 4.5.3.1.7. Pulmonary 4.5.3.2. Mexico Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 4.5.3.2.1. Therapeutic 4.5.3.2.2. Alpha Emitters 4.5.3.2.3. Beta Emitters 4.5.3.2.4. Brachytherapy Isotopes 4.5.3.2.5. Diagnostic 4.5.3.2.6. PET Radiopharmaceuticals 4.5.3.2.7. SPECT Radiopharmaceuticals 4.5.3.3. Mexico Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 4.5.3.3.1. Cardiology 4.5.3.3.2. Oncology 4.5.3.3.3. Thyroid 4.5.3.3.4. Neurology 4.5.3.3.5. Others 4.5.3.4. Mexico Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 4.5.3.4.1. Research Institutes 4.5.3.4.2. Hospitals 4.5.3.4.3. Diagnostic Centers 4.5.3.4.4. Others 5. Europe Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 5.2. Europe Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 5.3. Europe Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 5.4. Europe Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 5.5. Europe Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Country (2022-2029) 5.5.1. United Kingdom 5.5.1.1. United Kingdom Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 5.5.1.2. United Kingdom Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 5.5.1.3. United Kingdom Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User(2022-2029) 5.5.1.4. United Kingdom Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 5.5.2. France 5.5.2.1. France Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 5.5.2.2. France Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 5.5.2.3. France Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User(2022-2029) 5.5.2.4. France Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 5.5.3. Germany 5.5.3.1. Germany Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 5.5.3.2. Germany Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 5.5.3.3. Germany Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 5.5.3.4. Germany Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 5.5.4. Italy 5.5.4.1. Italy Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 5.5.4.2. Italy Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 5.5.4.3. Italy Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User(2022-2029) 5.5.4.4. Italy Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 5.5.5. Spain 5.5.5.1. Spain Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 5.5.5.2. Spain Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 5.5.5.3. Spain Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 5.5.5.4. Spain Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 5.5.6. Sweden 5.5.6.1. Sweden Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 5.5.6.2. Sweden Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 5.5.6.3. Sweden Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 5.5.6.4. Sweden Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 5.5.7. Austria 5.5.7.1. Austria Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 5.5.7.2. Austria Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 5.5.7.3. Austria Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 5.5.7.4. Austria Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 5.5.8. Rest of Europe 5.5.8.1. Rest of Europe Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 5.5.8.2. Rest of Europe Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 5.5.8.3. Rest of Europe Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 5.5.8.4. Rest of Europe Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 6. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 6.2. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 6.3. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 6.4. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 6.5. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Country (2022-2029) 6.5.1. China 6.5.1.1. China Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 6.5.1.2. China Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 6.5.1.3. China Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 6.5.1.4. China Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 6.5.2. S Korea 6.5.2.1. S Korea Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 6.5.2.2. S Korea Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 6.5.2.3. S Korea Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 6.5.2.4. S Korea Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 6.5.3. Japan 6.5.3.1. Japan Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 6.5.3.2. Japan Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 6.5.3.3. Japan Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 6.5.3.4. Japan Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 6.5.4. India 6.5.4.1. India Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 6.5.4.2. India Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 6.5.4.3. India Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 6.5.4.4. India Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 6.5.5. Australia 6.5.5.1. Australia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 6.5.5.2. Australia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 6.5.5.3. Australia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 6.5.5.4. Australia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 6.5.6. Indonesia 6.5.6.1. Indonesia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 6.5.6.2. Indonesia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 6.5.6.3. Indonesia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 6.5.6.4. Indonesia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 6.5.7. Malaysia 6.5.7.1. Malaysia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 6.5.7.2. Malaysia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 6.5.7.3. Malaysia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 6.5.7.4. Malaysia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 6.5.8. Vietnam 6.5.8.1. Vietnam Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 6.5.8.2. Vietnam Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 6.5.8.3. Vietnam Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User(2022-2029) 6.5.8.4. Vietnam Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 6.5.9. Taiwan 6.5.9.1. Taiwan Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 6.5.9.2. Taiwan Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 6.5.9.3. Taiwan Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 6.5.9.4. Taiwan Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 6.5.10. Rest of Asia Pacific 6.5.10.1. Rest of Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 6.5.10.2. Rest of Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 6.5.10.3. Rest of Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 6.5.10.4. Rest of Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 7. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 7.2. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 7.3. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 7.4. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 7.5. Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Country (2022-2029) 7.5.1. South Africa 7.5.1.1. South Africa Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 7.5.1.2. South Africa Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 7.5.1.3. South Africa Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 7.5.1.4. South Africa Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 7.5.2. GCC 7.5.2.1. GCC Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 7.5.2.2. GCC Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 7.5.2.3. GCC Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 7.5.2.4. GCC Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 7.5.3. Nigeria 7.5.3.1. Nigeria Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 7.5.3.2. Nigeria Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 7.5.3.3. Nigeria Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 7.5.3.4. Nigeria Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 7.5.4. Rest of ME&A 7.5.4.1. Rest of ME&A Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 7.5.4.2. Rest of ME&A Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 7.5.4.3. Rest of ME&A Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 7.5.4.4. Rest of ME&A Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 8. South America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 8.2. South America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 8.3. South America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User(2022-2029) 8.4. South America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 8.5. South America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Country (2022-2029) 8.5.1. Brazil 8.5.1.1. Brazil Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 8.5.1.2. Brazil Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 8.5.1.3. Brazil Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 8.5.1.4. Brazil Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 8.5.2. Argentina 8.5.2.1. Argentina Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 8.5.2.2. Argentina Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 8.5.2.3. Argentina Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 8.5.2.4. Argentina Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 8.5.3. Rest Of South America 8.5.3.1. Rest Of South America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Procedures (2022-2029) 8.5.3.2. Rest Of South America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Type (2022-2029) 8.5.3.3. Rest Of South America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by End User (2022-2029) 8.5.3.4. Rest Of South America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast, by Application (2022-2029) 9. Global Nuclear Medicine/Radiopharmaceuticals Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Nuclear Medicine/Radiopharmaceuticals Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Advanced Accelerator Applications S.A. 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Iba Molecular 10.3. Nordion, Inc. (A Subsidiary of Sterigenics International LLC.) 10.4. Eczacibasi-Monrol Nuclear Products 10.5. Siemens Healthcare 10.6. Sigma Aldrich Corporation 10.7. Bracco Imaging S.P.A 10.8. Bayer AG 10.9. Jubilant Pharma 10.10. Nordien, Inc. 10.11. Lantheus Medical Imaging, Inc. 10.12. GE Healthcare (A Fully-Owned Subsidiary of General Electric Company) 10.13. Mallinckrodt PLC 10.14. Cardinal Health, Inc. 10.15. Medtronic Plc. 10.16. Norgine B. V. 10.17. Curium 10.18. Eckert & Ziegler 10.19. NTP Radioisotopes 11. Key Findings 12. Industry Recommendations 13. Nuclear Medicine/Radiopharmaceuticals Market: Research Methodology 14. Terms and Glossary
  • INQUIRE BEFORE BUYING